Dr. Thomas Edgar Hutson DO Medical Oncologist

Dr. Thomas Hutson is a medical oncologist in Dallas, Texas. He is affiliated with multiple hospitals in the area, including Baylor University Medical Center and Medical City Dallas Hospital. He received his medical degree from Ohio University College of Osteopathic Medicine and has been in practice for 17 years. Dr. Hutson accepts several types of health insurance, listed below. He is one of 28 doctors at Baylor University Medical Center and one of 35 at Medical City Dallas Hospital who specialize in Medical Oncology.

Are you Dr. Thomas Hutson? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Baylor University Medical Center
High performing in Cancer

Medical City Dallas Hospital
High performing in Cancer

Education & Medical Training

Cleveland Clinic Foundation
Residency, Internal Medicine, 1997 - 2000

Cleveland Clinic Foundation
Fellowship, Hematology/Oncology, 2001 - 2004

Ohio University College of Osteopathic Medicine
Class of 1997

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Family Medicine
Certified in Sports Medicine

MA State Medical License
Active through 2014

FL State Medical License
Active through 2015

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2011

Publications & Presentations

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma.
Hutson, T. E.,Bukowski, R. M.,Rini, B. I.,Gore, M. E.,Larkin, J. M.,Figlin, R. A.,Barrios, C. H.,Escudier, B.,Lin, X.,Fly, K.,Martell, B.,Matczak, E.,Motzer, R. J.

Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
Hutson, T. E.,Escudier, B.,Esteban, E.,Bjarnason, G. A.,Lim, H. Y.,Pittman, K. B.,Senico, P.,Niethammer, A.,Lu, D. R.,Hariharan, S.,Motzer, R. J.

Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
Hutson, T. E.,Escudier, B.,Esteban, E.,Bjarnason, G. A.,Lim, H. Y.,Pittman, K. B.,Senico, P.,Niethammer, A.,Lu, D. R.,Hariharan, S.,Motzer, R. J.

See all 101 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.